More Globe Newswire

View Older Stories View Newer Stories

Nov 10, 2025 07:57AM Intermap Announces Date for Third Quarter Earnings
Nov 10, 2025 07:56AM Goldhale Launches AI-Powered Signal Tool to Enhance Trading Decision Support
Nov 10, 2025 07:55AM Datavault AI Files Lawsuit Against Wolfpack Research and Its Founder Dan David
Nov 10, 2025 07:55AM Datavault AI Files Lawsuit Against Wolfpack Research and Its Founder Dan David
Nov 10, 2025 07:46AM 2025 JETOUR Media Alliance Tech Tour Concludes Successfully
Nov 10, 2025 07:44AM Black Friday just got bigger: Hostinger raises discounts to help everyone start online
Nov 10, 2025 07:41AM BTDUex Global Mainnet Goes Live, Ushering in a New Era of Digital Asset Autonomy
Nov 10, 2025 07:41AM rabbitholes.fi Announces Presale on Gempad and Public ICO Dates
Nov 10, 2025 07:36AM GenesisCreditRestoration.com Expands Charitable Mission, Offering 100% Free, Full-Service Credit Repair to All
Nov 10, 2025 07:35AM Carpenter Technology Corporation Announces Proposed $700.0 Million Private Offering of Senior Notes Due 2034
Nov 10, 2025 07:35AM Applied Digital Announces Proposed Offering of $2.35 Billion of Senior Secured Notes
Nov 10, 2025 07:32AM Antalpha Reports Third Quarter 2025 Results
Nov 10, 2025 07:30AM Surgery Partners, Inc. Announces Third Quarter 2025 Results
Nov 10, 2025 07:30AM Tyson Foods Reports Fourth Quarter And Fiscal 2025 Results
Nov 10, 2025 07:30AM FreightCar America, Inc. Reports Third Quarter 2025 Results
Nov 10, 2025 07:30AM Bluejay Therapeutics’ Brelovitug (BJT-778) Monotherapy Achieved 100% Virologic Response and up to 82% Combined Endpoint of Virologic Response and ALT Normalization at Week 48 in Phase 2 Study in Chr
Nov 10, 2025 07:30AM OneMedNet Delivers on Revenue Model Promise with Palantir-Powered RWD Subscriptions: Live Feeds & AI Search
Nov 10, 2025 07:30AM FG Nexus to Present at the 2025 Cantor Crypto & AI/Energy Infrastructure Conference
Nov 10, 2025 07:30AM Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
Nov 10, 2025 07:30AM IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer
Nov 10, 2025 07:30AM Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships
Nov 10, 2025 07:30AM InflaRx Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU)
Nov 10, 2025 07:30AM Bakkt Reports Third Quarter 2025 Results
Nov 10, 2025 07:30AM OneMedNet Delivers on Revenue Model Promise with Palantir-Powered RWD Subscriptions: Live Feeds & AI Search
Nov 10, 2025 07:30AM Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
Nov 10, 2025 07:30AM SUNation Energy Announces 2025 Third Quarter Results and Reiterates 2025 Full Year Financial Guidance
Nov 10, 2025 07:30AM Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
Nov 10, 2025 07:30AM FG Nexus to Present at the 2025 Cantor Crypto & AI/Energy Infrastructure Conference
Nov 10, 2025 07:30AM Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Nov 10, 2025 07:30AM IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer
Nov 10, 2025 07:30AM Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Nov 10, 2025 07:30AM Matador Technologies Inc. Announces Closing of Convertible Note Facility to Expand Bitcoin Holdings
Nov 10, 2025 07:30AM Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments
Nov 10, 2025 07:29AM Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
Nov 10, 2025 07:29AM Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
Nov 10, 2025 07:25AM Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System
Nov 10, 2025 07:25AM Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
Nov 10, 2025 07:24AM Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History
Nov 10, 2025 07:22AM Wenlay Releases Cross-Chain Bridge Solution to Tackle Multi-Chain Liquidity Challenges
Nov 10, 2025 07:20AM Exodus Movement, Inc. Announces Acquisition of Grateful To Strengthen Stablecoin-Based Payments
Nov 10, 2025 07:20AM Alpha Modus Secures Patent License and Expands AI-Retail Ecosystem Through New Authorized Reseller Agreement
Nov 10, 2025 07:15AM AirBoss Defense Group Received Order CBRN Products Valued at $8.1M
Nov 10, 2025 07:12AM Genmab Announces Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes and Syndication of New Senior Secured Term Loan Facility
Nov 10, 2025 07:11AM Same-Day Loans with Guaranteed Approval and No Credit Check for Bad Credit Borrowers: Introduced by RadCred for Debt Relief
Nov 10, 2025 07:10AM Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results
Nov 10, 2025 07:05AM uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 10, 2025 07:05AM Outdoor Holding Company Reports Positive Net Income from Continuing Operations for Second Quarter Fiscal 2026
Nov 10, 2025 07:05AM VALLOUREC ANNOUNCES EXPANSION OF YOUNGSTOWN MANUFACTURING OPERATIONS
Nov 10, 2025 07:00AM Cielo Announces Closing of First Tranche of Unit Offering
Nov 10, 2025 07:00AM MAX Power Brings Together Leading Natural Hydrogen Experts for Technical Collaboration and Drill Site Visit
View Newer Stories View Older Stories